b
cell
hybridoma
import
sourc
monoclon
antibodi
paper
develop
highthroughput
method
character
mous
igg
antibodi
use
surfac
plasmon
reson
technolog
assay
rapidli
determin
subisotyp
whether
bind
nativ
antigen
approxim
affin
antigen
use
hybridoma
cell
cultur
supernat
moreov
found
mous
hybridoma
secret
igg
antibodi
also
membran
form
igg
express
without
base
surfac
igg
use
flow
cytometri
isol
rare
isotyp
switch
variant
antibodi
secret
hybridoma
cell
line
also
use
fluoresc
antigen
singl
cell
sort
antigen
bind
hybridoma
cell
bulk
mixtur
fuse
hybridoma
cell
instead
tradit
multimicrowel
plate
screen
limit
dilut
subclon
thu
save
time
labor
igg
monoclon
antibodi
specif
nativ
antigen
identifi
method
suitabl
vivo
therapeut
use
also
sandwich
elisa
assay
histolog
flow
cytometri
immun
precipit
xray
crystallographi
fig
isol
igg
antibodi
secret
cell
igg
hybridoma
cell
line
detect
igg
antibodi
secret
hybridoma
cell
igg
hybridoma
cell
line
elispot
b
cell
surfac
igg
stain
cell
c
enrich
igg
secret
cell
mac
singl
cell
sort
heavi
chain
switch
cell
biacor
test
igg
antibodi
switch
igg
antibodi
fig
sort
nativ
antigen
bind
igg
hybridoma
fusion
bulk
mixtur
stain
ova
specif
hybridoma
cell
line
fluoresc
ova
b
sort
ova
specif
hybridoma
cll
fusion
bulk
mixtur
introduct
b
cell
hybridoma
import
sourc
mous
monoclon
antibodi
mab
sinc
initi
product
common
approach
produc
hybridoma
fuse
b
cell
mice
hyperimmun
antigen
myeloma
b
cell
line
lack
hypoxanthin
guanin
phosphoribosyltransferas
hgprt
fusion
mixtur
seed
plate
hybridoma
select
hypoxanthineaminopterinthymidin
hat
contain
medium
kill
unfus
myeloma
cell
unfus
b
cell
ca
nt
prolifer
vitro
final
die
fuse
hybridoma
cell
surviv
hat
select
divid
commonli
supernat
well
show
hybridoma
growth
screen
antigenspecif
antibodi
use
antigen
coat
elisa
plate
cell
posit
well
subclon
limit
dilut
retest
sure
monoclon
year
mani
use
mous
monoclon
antibodi
success
made
fusion
screen
method
howev
two
major
shortcom
first
mice
hyperimmun
solubl
protein
produc
antibodi
specif
nativ
protein
also
specif
epitop
uniqu
denatur
protein
especi
adjuv
freund
adjuv
alum
use
immun
latter
antibodi
use
detect
denatur
protein
western
blot
antibodi
specif
nativ
antigen
much
wider
rang
applic
includ
vivo
therapeut
reagent
well
sandwich
elisa
assay
histolog
flow
cytometri
immun
precipit
xray
crystallographi
assay
perform
antigenco
elisa
well
gener
ca
nt
distinguish
antibodi
recogn
nativ
vs
denatur
form
antigen
protein
sinc
absorpt
elisa
plate
denatur
protein
due
hydrophob
interact
plate
surfac
protein
second
shortcom
tradit
mab
select
method
labor
time
consum
sever
round
plate
seed
select
antibodi
fulli
character
overcom
shortcom
develop
rapid
method
character
mous
igg
antibodi
singl
cell
sort
antigen
specif
igg
hybridoma
cell
captur
potenti
antigenspecif
mab
hybridoma
cultur
supernat
within
flow
cell
biacor
biasensor
chip
contain
immobil
antifc
antibodi
specif
individu
mous
igg
isotyp
surfac
plasmon
reson
spr
signal
identifi
mab
isotyp
captur
mab
test
abil
bind
nativ
antigen
follow
bind
kinet
spr
mab
affin
estim
also
found
mous
hybridoma
cell
secret
igg
antibodi
surfac
form
igg
lack
bind
antigen
normal
use
fluoresc
antigen
bound
surfac
igg
singl
cell
sort
hybridoma
cell
secret
mab
specif
nativ
antigen
biacor
chip
purchas
ge
healthcar
goat
antimous
igg
fc
specif
specif
antibodi
bought
jackson
immunoresearch
akp
conjug
antimous
antibodi
bd
pharmingen
actin
antibodi
cell
signal
technolog
rabbit
polyclon
antibodi
gift
dr
john
cambier
lab
ovalbumin
ova
purchas
sigma
nativ
ova
protein
obtain
dissolv
ova
pb
collect
monomer
ova
peak
superdex
size
column
use
fast
protein
liquid
chromatographi
fplc
alexa
fluor
conjug
ova
protein
purchas
life
technolog
antialexa
fluor
microbead
microbead
ls
column
meltenyi
biotec
bcip
promega
lanac
adjuv
provid
dr
steven
dow
spike
protein
sarscov
made
dr
chengyu
jiang
lab
mice
purchas
jackson
lab
kept
specif
pathogen
free
environ
naiton
jewish
health
mice
experi
carri
strict
accord
guid
care
use
laboratori
anim
nation
institut
health
protocol
approv
nation
jewish
health
institut
anim
care
use
committe
hybridoma
cell
maltos
bind
protein
mbp
made
fusion
mbp
immun
mice
spleen
cell
lab
hybridoma
cell
spike
protein
sarscov
made
xia
hong
janic
white
hybrdoma
cell
line
ova
made
laura
noge
janic
white
laboratori
hybridoma
cell
line
gift
libus
jerabek
goat
antimous
igg
fc
subclass
specif
antibodi
immobil
flowcel
biacor
per
manufactur
instruct
antibodi
dissolv
sodium
acet
surfac
activ
nhydroxysuccinimid
nh
ethyl
dimethylaminopropyl
carbodiimid
edc
one
four
antibodi
inject
differ
channel
chip
conjug
achiev
coval
coupl
antibodi
surfac
chip
around
ru
antibodi
immobil
channel
unoccupi
activ
site
chip
block
inject
ethanolamin
old
balbc
mice
immun
intraperiton
three
time
ova
protein
mix
lanac
liposom
unmethyl
dna
one
week
interv
ova
antibodi
titer
mous
serum
confirm
elisa
use
ova
coat
plate
ova
pb
inject
intraperiton
boost
three
day
sacrif
mice
mous
hybridoma
cell
line
secret
mous
antibodi
respect
stain
goat
anti
mous
heavi
chain
fc
region
isotyp
specif
antibodi
control
antibodi
stain
carri
ice
minut
cell
surfac
stain
detect
facscan
splenocyt
fuse
myeloma
cell
instead
tradit
plate
fuse
cell
cultur
flask
hat
ad
follow
day
day
fusion
dead
cell
remov
pi
stain
live
cell
stain
alexa
fluor
conjug
goat
antimous
igg
antibodi
alexa
fluor
conjug
ova
cell
secret
antibodi
nativ
ova
also
stain
posit
control
gate
purpos
moflo
xdp
use
singl
cell
sort
doubl
posit
hybridoma
cell
rtpcr
igg
heavi
chain
hybridoma
cell
mrna
hybridoma
cell
extract
trizol
first
stand
cdna
made
use
oligodt
primer
common
forward
primer
differ
revers
primer
target
end
secret
membran
form
igg
heavi
chain
use
rtpcr
use
taq
polymeras
pcr
product
separ
agaros
gel
verifi
sequenc
primer
use
list
tabl
elisa
plate
coat
sarscov
spike
protein
express
cell
overnight
block
smem
cell
cultur
medium
contain
fb
serial
dilut
hybridoma
cell
incub
well
cell
incub
cell
discard
plate
wash
pb
contain
triton
akp
conjug
antimous
antibodi
ad
incub
hour
room
temperatur
extens
wash
pb
contain
triton
spot
develop
bcip
esa
buffer
trishcl
nacl
mgcl
enrich
antibodi
secret
cell
antibodi
secret
hybridoma
cell
million
hybridoma
cell
stain
alexa
fluor
conjug
goat
antimous
antibodi
wash
incub
antialexa
fluor
microbead
microbead
bound
cell
retain
ls
column
magnet
field
recov
remov
magnet
field
recov
cell
stain
alexa
fluor
conjug
goat
antimous
antibodi
moflo
xdp
flow
cytometri
instrument
use
singl
cell
sort
enrich
popul
well
microcultur
plate
hybridoma
cell
beadpurifi
b
cell
wash
twice
icecold
pb
lyse
ripa
buffer
purifi
b
cell
use
posit
control
cell
lysat
load
sdspage
transfer
nitrocellulos
membran
probe
antiig
antibodi
actin
also
probe
load
control
discrimin
mab
bind
nativ
vs
denatur
form
protein
antigen
use
surfac
plasmon
reson
spr
technolog
biacor
instrument
follow
increas
refract
index
occur
protein
bind
surfac
flowcel
coval
immobil
four
differ
polyclon
goat
antimous
igg
fc
isotyp
specif
antibodi
recogn
mous
respect
gold
surfac
four
differ
flowcel
biacor
biasensor
chip
fig
goat
antibodi
target
fc
region
mous
antibodi
high
bind
affin
mous
fc
hybridoma
supernat
contain
igg
mab
inject
four
flowcel
captur
tabl
primer
use
amplifi
secret
membran
form
mous
igg
primer
sequenc
well
appropri
antifc
specif
thu
identifi
mab
isotyp
high
affin
polyclon
antifc
reagent
result
stabl
bind
fig
flowcel
act
neg
control
nonspecif
bind
fluid
phase
spr
signal
cultur
supernat
sinc
mab
captur
via
fc
region
two
fab
arm
free
interact
antigen
inject
nativ
immun
protein
tell
whether
captur
mab
recogn
nativ
protein
exampl
mab
produc
ovaimmun
mice
previous
score
bind
ova
protein
coat
standard
elisa
plate
howev
mab
captur
via
fc
within
fc
flowcel
fig
subsequ
inject
nativ
ova
bound
mab
mab
show
epitop
present
nativ
ova
protein
furthermor
sinc
ova
monoval
antigen
bind
kinet
follow
via
spr
signal
could
analyz
estim
affin
mab
bind
nativ
ova
fig
analysi
done
less
mab
cultur
supernat
anoth
use
variat
experi
shown
fig
three
mab
specif
nativ
maltos
bind
protein
mbp
character
mab
mab
use
biacor
system
determin
whether
mab
recogn
differ
epitop
antigen
protein
test
separ
three
mab
bound
nativ
mbp
fig
test
whether
antibodi
recogn
differ
epitop
mbp
antibodi
first
captur
chip
nativ
mbp
inject
bound
antibodi
antibodi
inject
sequenc
fig
mbp
bound
mab
subsequ
fail
bind
mab
indic
epitop
block
mab
howev
mab
bound
well
captur
mbp
indic
epitop
well
separ
fig
type
data
allow
rapid
identif
pair
mab
use
develop
sandwich
elisa
assay
fig
show
standard
sandwich
elisa
data
use
well
coat
purifi
mab
captur
variou
concentr
mbp
subsequ
detect
mab
mab
vivo
therapeut
use
mab
block
receptorligand
interact
success
use
mab
must
bind
receptor
ligand
epitop
lie
within
interfac
interact
fig
show
spr
method
use
identifi
use
mab
type
two
mab
specif
spike
protein
sar
coronaviru
sarscov
either
two
mab
captur
fc
flowcel
bound
inject
nativ
spike
protein
howev
subsequ
inject
solubl
version
angiotensin
convert
enzym
spike
receptor
bound
captur
spike
protein
fail
bind
captur
spike
protein
result
identifi
mab
potenti
therapeut
mab
block
interact
sarscov
cellular
receptor
robust
goat
antiigg
fc
reagent
allow
flowcel
experi
strip
captur
mab
antigen
low
ph
glycin
buffer
ph
wash
without
signific
damag
immobil
antifc
reagent
thu
singl
biasensor
chip
use
hundr
experi
heavi
chain
secret
membran
form
immunoglobulin
produc
singl
rna
transcript
differenti
splice
nonactiv
b
cell
splice
result
virtual
exclus
product
membran
form
fulli
differenti
antibodi
secret
cell
mrna
express
secret
form
predomin
surfac
form
still
produc
also
document
mab
secret
b
cell
hybridoma
confirm
observ
hybridoma
produc
myeloma
fusion
partner
success
stain
cell
variou
fluoresc
antiigg
fc
reagent
fig
also
demonstr
presenc
membran
form
heavi
chain
mrna
hybridoma
although
level
much
reduc
secret
form
fig
interestingli
could
detect
express
one
surfac
igg
associ
molecul
involv
b
cell
signal
either
igg
produc
hybridoma
suggest
surfac
igg
signal
receptor
fig
perform
addit
experi
assur
tight
associ
hybridoma
cell
surfac
express
igg
secret
igg
previous
singl
cell
clone
hybridoma
cell
line
describ
began
lose
igg
secret
cultur
time
found
cell
express
surfac
igg
fig
howev
sort
hybridoma
cell
without
surfac
igg
express
respect
could
detect
antibodi
secret
hybridoma
cell
surfac
igg
express
fig
furthermor
heterogen
hybridoma
cell
subclon
limit
dilut
clone
secret
antibodi
surfac
igg
express
fig
show
cell
surfac
igg
express
deriv
mous
hybridoma
cell
correl
abil
secret
mab
isotyp
other
suggest
antigen
specif
hybridoma
select
cell
surfac
ig
express
stabl
antibodi
secretor
compar
tradit
plate
select
hybridoma
mani
purpos
eg
viral
protect
complement
fixat
prepar
fab
fragment
physic
properti
effector
function
mous
mab
prefer
genet
upstream
isotyp
report
switch
heavi
chain
downstream
isotyp
mous
hybridoma
cell
line
occur
extrem
low
detect
rate
allow
use
heavi
chain
isotyp
specif
antibodi
isol
switch
variant
sever
round
select
use
find
presenc
surfac
igg
hybridoma
correl
secret
igg
improv
method
isol
igg
class
switch
variant
mab
start
mous
hybridoma
cell
line
produc
mab
sarscov
spike
protein
analyz
cell
use
elispot
assay
found
switch
variant
exist
cell
line
rate
per
cell
fig
cell
undetect
direct
flow
cytometri
use
antibodi
specif
abl
enrich
magnet
bead
point
cell
could
identifi
flow
cytometri
singlecel
sort
produc
clone
fig
start
million
cell
sort
cell
grew
coloni
secret
instead
bound
spike
protein
affin
parent
antibodi
fig
also
express
v
h
v
l
sequenc
parent
antibodi
data
shown
direct
isol
antigen
specif
hybridoma
bulk
cultur
fuse
cell
use
spr
initi
hybridoma
cultur
supernat
greatli
speed
character
mab
time
consum
process
make
mab
select
clone
hybridoma
cell
secret
desir
antigenspecif
mab
normal
initi
fuse
cell
distribut
multipl
microcultur
plate
dilut
estim
produc
less
one
hat
resist
hybridoma
per
well
sinc
fusion
myeloma
cell
select
mani
result
hat
resist
hybridoma
produc
mab
specif
immun
antigen
therefor
well
grow
hybridoma
must
screen
mab
specif
also
problem
aris
miscalcul
cell
dilut
result
well
multipl
hat
resist
hybridoma
cell
one
secret
desir
mab
furthermor
sinc
fusion
initi
daughter
cell
fuse
hybridoma
cell
tend
lose
chromosom
progeni
well
aris
longer
secret
mab
therefor
hybridoma
cell
posit
cultur
well
must
clone
rescreen
overgrowth
desir
mab
produc
hybridoma
cell
hat
resist
cell
cultur
well
perform
set
experi
see
surfac
igg
hybridoma
cell
could
use
solv
problem
reduc
time
effort
produc
clone
stabl
clonal
hybridoma
cell
produc
use
mab
develop
method
use
fluoresc
antimous
igg
antibodi
fluoresc
antigen
singl
cell
sort
antigenspecif
hybridoma
cell
fusion
bulk
mixtur
directli
target
nativ
antigen
specif
hybridoma
first
show
fluoresc
label
ova
stain
hybridoma
cell
line
produc
antiova
specif
igg
mab
fig
fuse
spleen
cell
ova
immun
mice
fusion
partner
standard
way
instead
cultur
select
hybridoma
microcultur
plate
grew
bulk
cultur
hat
day
kill
unfus
cell
remain
cell
stain
antiigg
identifi
igg
produc
hybridoma
also
fluoresc
ova
reagent
identifi
specif
ova
cell
posit
antibodi
occur
frequenc
less
live
cell
popul
fig
singl
doubl
posit
cell
sort
individu
cultur
well
three
microcultur
plate
day
supernat
result
coloni
test
ova
specif
igg
secret
select
method
effici
accur
well
hybridoma
cell
grow
nearli
secret
igg
antibodi
bind
nativ
antigen
tabl
sinc
almost
clone
secret
antibodi
randomli
select
clone
v
h
v
l
sequenc
five
six
clone
v
h
v
l
sequenc
suggest
least
clonal
outgrowth
bulk
cultur
data
shown
neg
control
also
singl
cell
sort
one
plate
surfac
igg
posit
ova
neg
clone
result
coloni
secret
igg
one
secret
antibodi
bind
nativ
ova
hybridoma
cell
later
found
posit
stain
ova
sort
hybridoma
cell
might
due
system
error
thu
select
method
greatli
improv
detect
select
hybridoma
produc
mab
bind
nativ
form
immun
antigen
prior
initi
screen
antibodi
specif
paper
optim
two
method
greatli
streamlin
product
character
mab
especi
specif
epitop
present
nativ
protein
first
use
spr
small
amount
primari
hybridoma
supernat
identifi
quickli
igg
isotop
mab
abil
bind
nativ
antigen
affin
antigen
second
use
flow
cytometri
take
advantag
strong
correl
hybridoma
secret
surfac
igg
order
isol
either
rare
cell
hybridoma
cultur
switch
use
genet
downstream
isotyp
rare
antigenspecif
hybridoma
heterogen
mixtur
hybridoma
cell
grown
bulk
immedi
follow
fusion
taken
togeth
method
greatli
reduc
time
effort
requir
go
initi
fusion
isol
hybridoma
clone
produc
mab
appropri
specif
function
downstream
applic
method
use
find
appropri
mab
research
commerci
therapeut
use
shown
exampl
use
identifi
switch
variant
rapidli
identifi
mab
suitabl
sandwich
elisa
identifi
mab
capabl
prevent
virusreceptor
interact
howev
potenti
use
well
exampl
laboratori
use
antibodi
success
improv
cocrystal
trial
antigen
difficult
crystal
thought
antibodi
work
shield
unstructur
highli
mobil
region
protein
disrupt
intern
crystal
contact
exampl
success
cocrystal
transcript
factor
fab
region
specif
antibodi
bind
fab
essenti
crystal
immobil
ctermin
flexibl
although
explor
use
one
could
imagin
abil
sort
hybridoma
cell
base
surfac
bind
fluoresc
antigen
might
use
screen
igg
vregion
mutant
librari
order
evolv
mab
higher
affin
igg
type
vitro
affin
matur
experi
often
done
via
igg
surfac
display
phage
yeast
system
allow
construct
larg
librari
antibodi
express
well
organ
problem
would
circumv
b
cell
hybridoma
surfac
express
modern
retrovir
express
system
also
allow
larg
scale
mutant
librari
moreov
simultan
surfac
express
secret
mab
would
make
immedi
avail
vitro
vivo
function
experi
other
found
surfac
form
igg
receptor
hybridoma
lack
signal
coreceptor
may
advantag
use
propos
involv
engag
surfac
igg
antibodi
antigen
order
isol
cell
lack
signal
engag
receptor
may
head
activ
untoward
downstream
signal
pathway
could
induc
apoptosi
sp
singl
posit
stain
antiigg
antibodi
neg
stain
ova
mean
antibodi
bind
nativ
ova
mean
antibodi
bind
nativ
ova
biacor
test
two
hybridoma
secret
igg
antibodi
bind
nativ
ova
vh
vk
